In vitro study of the Polo-like kinase 1 inhibitor volasertib in non-small-cell lung cancer reveals a role for the tumor suppressor p53
about
In vitro study of the Polo-like kinase 1 inhibitor volasertib in non-small-cell lung cancer reveals a role for the tumor suppressor p53
description
im Mai 2019 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 05 April 2019
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2019
@uk
name
In vitro study of the Polo-lik ...... e for the tumor suppressor p53
@en
In vitro study of the Polo-lik ...... e for the tumor suppressor p53
@nl
type
label
In vitro study of the Polo-lik ...... e for the tumor suppressor p53
@en
In vitro study of the Polo-lik ...... e for the tumor suppressor p53
@nl
prefLabel
In vitro study of the Polo-lik ...... e for the tumor suppressor p53
@en
In vitro study of the Polo-lik ...... e for the tumor suppressor p53
@nl
P2093
P921
P356
P1433
P1476
In vitro study of the Polo-lik ...... e for the tumor suppressor p53
@en
P2093
An Wouters
Christophe Hermans
Filip Lardon
Hilde Lambrechts
Ines De Pauw
Jan Baptist Vermorken
Jolien Van den Bossche
Marc Peeters
Patrick Pauwels
Pol Specenier
P304
P356
10.1002/1878-0261.12477
P407
P577
2019-04-05T00:00:00Z